Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

por Rubio-Terrés, C., Soria, J. M., Morange, P. E., Souto, J. C., Suchon, P., Mateo, J., Saut, N., Rubio-Rodríguez, D., Sala, J., Gracia, A., Pich, S., Salas, E.
Publicado 2015

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk

por Suchon, P., Germain, M., Delluc, A., Smadja, D., Jouven, X., Gyorgy, B., Saut, N., Ibrahim, M., Deleuze, J. F., Alessi, M. C., Morange, P. E., Trégouët, D. A.
Publicado 2017

Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors

por Venton, G, Pérez-Alea, M, Baier, C, Fournet, G, Quash, G, Labiad, Y, Martin, G, Sanderson, F, Poullin, P, Suchon, P, Farnault, L, Nguyen, C, Brunet, C, Ceylan, I, Costello, R T
Publicado 2016

Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation

por Ibrahim-Kosta, M., Suchon, P., Couturaud, F., Smadja, D., Olaso, R., Germain, M., Saut, N., Goumidi, L., Derbois, C., Thibord, F., Debette, S., Amouyel, P., Deleuze, J. F., van Doorn, P., Castoldi, E., Patin, E., Alessi, M. C., Trégouët, D. A., Morange, P. E.
Publicado 2019